← brief for 2026-09-03 · Slowing decline

Estimation of risk of nephrogenic systemic fibrosis inpatients of stage 3-5 chronic kidney disease undergoing magnetic resonance imaging with injectable gadobutrol.

Key takeaways

This study looked at people with stage 3 to 5 kidney disease who had an MRI scan using gadobutrol, one of the newer gadolinium dyes. It checked how many later developed nephrogenic systemic fibrosis, a rare condition where the skin and other tissue thicken and harden. The risk was estimated from records of patients who were scanned, so it shows what happened in this group rather than proving cause. It matters because older gadolinium dyes were the reason many people with weak kidneys were told to avoid MRI dye at all.

Who did this work

Muhammad Zahid (Lahore General Hospital) · Javaid Asghar (Doctors Hospital) · Furqan Ahmad (Lahore General Hospital) · Adeel Asghar (Doctors Hospital) · Ahmad Raza Khan (Doctors Hospital) · Dr Atiqa Ijaz (Doctors Hospital)

Source

Paper · OpenAlex, CKD works · 2026-09-01
https://doi.org/10.29309/tpmj/2026.33.09.10523